Racial Disparities in Response to an FDA Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma - Journal of Minimally Invasive Gynecology

Racial Disparities in Response to an FDA Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma  Journal of Minimally Invasive Gynecology

Introduction; Materials and Methods; Results; Discussion; Conclusion; References. Jump to Section, Introduction, Materials and Methods, Results, Discussion ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more